{"id":1936,"date":"2025-11-18T09:44:00","date_gmt":"2025-11-18T09:44:00","guid":{"rendered":"https:\/\/www.innothyrogen.eu\/uncategorized-hr\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\/"},"modified":"2025-12-10T09:58:29","modified_gmt":"2025-12-10T09:58:29","slug":"innothyrogen-na-62-onkoloskom-kongresu-u-beogradu","status":"publish","type":"post","link":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\/","title":{"rendered":"InnoThyroGen na 62. onkolo\u0161kom kongresu u Beogradu"},"content":{"rendered":"\n

Uvod u InnoThyroGen na 62. onkolo\u0161kom kongresu<\/strong><\/h2>\n\n

Od 11. do 15. studenog 2025.<\/strong>, Beograd je bio doma\u0107in 62. onkolo\u0161kog kongresa<\/strong>, jednog od vode\u0107ih regionalnih doga\u0111aja posve\u0107enih napretku onkologije, dijagnostike i personalizirane terapije.Kongres je okupio lije\u010dnike, istra\u017eiva\u010de, farmaceute, laboratorijske specijaliste i mnoge druge zdravstvene djelatnike<\/strong>.Tijekom ovog va\u017enog doga\u0111aja, dr. Branka Zuki\u0107<\/a><\/strong> iz IMGGE<\/a> predstavljala je projekt InnoThyroGen<\/strong> i sudjelovala dva uzastopna dana, doprinose\u0107i znanstvenim predavanjem i moderiranom panel raspravom.<\/p>\n\n

1. dan: InnoThyroGen na 62. onkolo\u0161kom kongresu kroz plenarno predavanje<\/strong><\/h2>\n\n

Prvog dana, dr. Zuki\u0107 odr\u017eala je predavanje pod naslovom:\u201eIntegracija genomske medicine u zdravstveni sustav Srbije: od pilot projekata do sustavne transformacije.\u201c<\/strong><\/p>\n\n

Tijekom svog izlaganja, naglasila je teku\u0107e napore srpskih istra\u017eiva\u010da da znanstvene spoznaje prevedu u metodologije molekularne dijagnostike.Ove metodologije podr\u017eavaju preciznu onkologiju i personaliziranu terapiju<\/strong>, omogu\u0107uju\u0107i to\u010dniju stratifikaciju pacijenata i pobolj\u0161ane ishode lije\u010denja.Nadalje, istaknula je va\u017enost da takva napredna dijagnostika bude dostupna svim pacijentima u Srbiji<\/strong>, osiguravaju\u0107i jednakost u zdravstvenoj skrbi.<\/p>\n\n

Osim toga, dr. Zuki\u0107 raspravljala je o nekoliko aktivnosti provedenih u okviru projekta InnoThyroGen<\/strong>. Predstavila je teku\u0107i rad na personaliziranom mapiranju ekosustava<\/strong> i identifikaciji dionika<\/strong>, \u0161to je klju\u010dno za podr\u0161ku genomskoj medicini i ja\u010danje dugoro\u010dnog utjecaja projekta. <\/p>\n\n

Utjecaj predavanja 1. dana<\/strong><\/h2>\n\n

Predavanje je pomoglo u predstavljanju projekta InnoThyroGen velikoj publici stru\u010dnjaka usmjerenih na onkologiju.Kao rezultat toga, postignuto je nekoliko va\u017enih ishoda:<\/p>\n\n

    \n
  • Pove\u0107ana svijest o napretku Srbije u genomskoj medicini<\/li>\n\n\n\n
  • Bolje razumijevanje uloge koju precizna dijagnostika mo\u017ee imati u onkologiji<\/li>\n\n\n\n
  • Ja\u010da vidljivost InnoThyroGena me\u0111u klini\u010darima i molekularnim stru\u010dnjacima<\/li>\n\n\n\n
  • Pobolj\u0161ano prepoznavanje mapiranja ekosustava kao alata za budu\u0107u transformaciju zdravstvene skrbi<\/li>\n<\/ul>\n\n

    Posljedi\u010dno, znanstvena vrijednost i dugoro\u010dni ciljevi projekta postali su jasniji nacionalnim i regionalnim dionicima.<\/p>\n\n

    2. dan: InnoThyroGen na 62. onkolo\u0161kom kongresu kroz panel raspravu<\/strong><\/h2>\n\n

    Drugog dana, dr. Zuki\u0107 moderirala je panel \u201eInovacije zajedno: kada se istra\u017eivanje susre\u0107e s klini\u010dkom praksom.\u201c<\/strong>Rasprava je istra\u017eila kako suradnja izme\u0111u klini\u010dara i istra\u017eiva\u010da mo\u017ee stvoriti osjetljiviji i inovativniji zdravstveni sustav.<\/p>\n\n

    Panelisti su istaknuli va\u017enost ugra\u0111ivanja istra\u017eivanja i razvoja izravno u klini\u010dke postavke.Kao rezultat toga, znanstvena otkri\u0107a mogu se br\u017ee prevesti u prakti\u010dnu upotrebu, dok klini\u010dari dobivaju alate koji istinski pobolj\u0161avaju njihov svakodnevni rad.Nadalje, u dijalogu je istaknuto da je sinergija izme\u0111u istra\u017eivanja i prakse klju\u010dna za osiguravanje kontinuiranog pobolj\u0161anja ishoda lije\u010denja pacijenata.<\/p>\n\n

    Utjecaj panela 2. dana<\/strong><\/h2>\n\n

    Tijekom rasprave, sudionici su naglasili va\u017enost timskog rada i me\u0111usektorske suradnje.Dodatno, panel je predstavio projekt InnoThyroGen kao primjer kako regionalno mapiranje zdravstvenog ekosustava i strukturirani putovi za translaciju mogu proizvesti zna\u010dajan utjecaj.<\/p>\n\n

    Klju\u010dni ishodi uklju\u010duju:<\/p>\n\n

      \n
    • Pove\u0107an interes za izgradnju sna\u017enog personaliziranog zdravstvenog ekosustava<\/li>\n\n\n\n
    • Ve\u0107e prepoznavanje suradnje dionika kao temelja za inovacije<\/li>\n\n\n\n
    • Ja\u010da vidljivost inicijativa koje financira EU kao alata za ubrzavanje genomske medicine<\/li>\n\n\n\n
    • Dublje razumijevanje relevantnosti InnoThyroGena u integraciji istra\u017eivanja i klini\u010dke prakse<\/li>\n<\/ul>\n\n

      Sveukupno, InnoThyroGen na 62. onkolo\u0161kom kongresu<\/strong> pokazao je kako koordinirani napori mogu oja\u010dati istra\u017eiva\u010dke kapacitete i podr\u017eati klini\u010dku implementaciju diljem regije.<\/p>\n\n

      Zaklju\u010dak<\/strong><\/h2>\n\n

      62. onkolo\u0161ki kongres u Beogradu pru\u017eio je izvrsnu platformu za predstavljanje znanstvenog napretka i poticanje dijaloga izme\u0111u klini\u010dkih i istra\u017eiva\u010dkih zajednica.Kroz svoje predavanje i moderiranje panela, dr. Zuki\u0107 je uspje\u0161no istaknula va\u017enost genomske medicine, suradnje i dugoro\u010dnog razvoja ekosustava.Stoga, InnoThyroGen na 62. onkolo\u0161kom kongresu<\/strong> nastavlja doprinositi transformaciji onkologije i personalizirane zdravstvene skrbi u Srbiji.<\/p>\n\n

      Ostanite u tijeku<\/strong><\/h2>\n\n

      Pratite nas za vi\u0161e novosti s nadolaze\u0107ih znanstvenih doga\u0111aja.Dodatno, pratite InnoThyroGen<\/strong> na LinkedInu, X (Twitteru), Facebooku i Instagramu<\/strong> za nove aktivnosti, najave i istra\u017eiva\u010dke uvide.<\/p>\n\n

      \n
      \"\"<\/figure>\n\n\n\n
      \"\"<\/figure>\n<\/figure>\n","protected":false},"excerpt":{"rendered":"

      Uvod u InnoThyroGen na 62. onkolo\u0161kom kongresu Od 11. do 15. studenog 2025., Beograd je bio doma\u0107in 62. onkolo\u0161kog kongresa, jednog od vode\u0107ih regionalnih doga\u0111aja posve\u0107enih napretku onkologije, dijagnostike i personalizirane terapije.Kongres je okupio lije\u010dnike, istra\u017eiva\u010de, farmaceute, laboratorijske specijaliste i mnoge druge zdravstvene djelatnike.Tijekom ovog va\u017enog doga\u0111aja, dr. Branka Zuki\u0107 iz IMGGE predstavljala je projekt […]<\/p>\n","protected":false},"author":1,"featured_media":1937,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[40],"tags":[],"class_list":["post-1936","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vijesti"],"yoast_head":"\nInnoThyroGen na 62. onkolo\u0161kom kongresu u Beogradu<\/title>\n<meta name=\"description\" content=\"InnoThyroGen na 62. onkolo\u0161kom kongresu: Dr. Branka Zuki\u0107 odr\u017eala je predavanje i moderirala panel u Beogradu, podi\u017eu\u0107i vidljivost genomske medicine i ja\u010daju\u0107i suradnju izme\u0111u istra\u017eivanja i klini\u010dke prakse.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\/\" \/>\n<meta property=\"og:locale\" content=\"hr_HR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"InnoThyroGen na 62. onkolo\u0161kom kongresu u Beogradu\" \/>\n<meta property=\"og:description\" content=\"InnoThyroGen na 62. onkolo\u0161kom kongresu: Dr. Branka Zuki\u0107 odr\u017eala je predavanje i moderirala panel u Beogradu, podi\u017eu\u0107i vidljivost genomske medicine i ja\u010daju\u0107i suradnju izme\u0111u istra\u017eivanja i klini\u010dke prakse.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\/\" \/>\n<meta property=\"og:site_name\" content=\"InnoThyroGen EU projekt\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61571994011521\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-18T09:44:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-10T09:58:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/12\/KN2025-Branka.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"1536\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@innothyrogenEU\" \/>\n<meta name=\"twitter:site\" content=\"@innothyrogenEU\" \/>\n<meta name=\"twitter:label1\" content=\"Napisao\/la\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Procijenjeno vrijeme \u010ditanja\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#\\\/schema\\\/person\\\/f6b134e97e8e2d2e2289a7953108188b\"},\"headline\":\"InnoThyroGen na 62. onkolo\u0161kom kongresu u Beogradu\",\"datePublished\":\"2025-11-18T09:44:00+00:00\",\"dateModified\":\"2025-12-10T09:58:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\\\/\"},\"wordCount\":640,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.innothyrogen.eu\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/KN2025-Branka.jpg\",\"articleSection\":[\"Vijesti\"],\"inLanguage\":\"hr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\\\/\",\"url\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\\\/\",\"name\":\"InnoThyroGen na 62. onkolo\u0161kom kongresu u Beogradu\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.innothyrogen.eu\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/KN2025-Branka.jpg\",\"datePublished\":\"2025-11-18T09:44:00+00:00\",\"dateModified\":\"2025-12-10T09:58:29+00:00\",\"description\":\"InnoThyroGen na 62. onkolo\u0161kom kongresu: Dr. Branka Zuki\u0107 odr\u017eala je predavanje i moderirala panel u Beogradu, podi\u017eu\u0107i vidljivost genomske medicine i ja\u010daju\u0107i suradnju izme\u0111u istra\u017eivanja i klini\u010dke prakse.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\\\/#breadcrumb\"},\"inLanguage\":\"hr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.innothyrogen.eu\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/KN2025-Branka.jpg\",\"contentUrl\":\"https:\\\/\\\/www.innothyrogen.eu\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/KN2025-Branka.jpg\",\"width\":2048,\"height\":1536},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Po\u010detna\",\"item\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"InnoThyroGen na 62. onkolo\u0161kom kongresu u Beogradu\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#website\",\"url\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/\",\"name\":\"InnoThyroGen EU Project\",\"description\":\"Inovacije u zdravlju \u0161titnja\u010de s genomikom i prediktivnim algoritmima kroz suradni\u010dku izvrsnost\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"hr\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#organization\",\"name\":\"InnoThyroGen EU projekt\",\"url\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.innothyrogen.eu\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/logo_EMAIL_without_bacground_vertical.png\",\"contentUrl\":\"https:\\\/\\\/www.innothyrogen.eu\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/logo_EMAIL_without_bacground_vertical.png\",\"width\":534,\"height\":520,\"caption\":\"InnoThyroGen EU projekt\"},\"image\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61571994011521\",\"https:\\\/\\\/x.com\\\/innothyrogenEU\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/innothyrogen-eu-project\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#\\\/schema\\\/person\\\/f6b134e97e8e2d2e2289a7953108188b\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7ddcd85f5d67b5a8ee8daedcc5e9afa1fef935b44ea366e04fb0f0185cea3977?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7ddcd85f5d67b5a8ee8daedcc5e9afa1fef935b44ea366e04fb0f0185cea3977?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7ddcd85f5d67b5a8ee8daedcc5e9afa1fef935b44ea366e04fb0f0185cea3977?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/www.innothyrogen.eu\"],\"url\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"InnoThyroGen na 62. onkolo\u0161kom kongresu u Beogradu","description":"InnoThyroGen na 62. onkolo\u0161kom kongresu: Dr. Branka Zuki\u0107 odr\u017eala je predavanje i moderirala panel u Beogradu, podi\u017eu\u0107i vidljivost genomske medicine i ja\u010daju\u0107i suradnju izme\u0111u istra\u017eivanja i klini\u010dke prakse.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\/","og_locale":"hr_HR","og_type":"article","og_title":"InnoThyroGen na 62. onkolo\u0161kom kongresu u Beogradu","og_description":"InnoThyroGen na 62. onkolo\u0161kom kongresu: Dr. Branka Zuki\u0107 odr\u017eala je predavanje i moderirala panel u Beogradu, podi\u017eu\u0107i vidljivost genomske medicine i ja\u010daju\u0107i suradnju izme\u0111u istra\u017eivanja i klini\u010dke prakse.","og_url":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\/","og_site_name":"InnoThyroGen EU projekt","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61571994011521","article_published_time":"2025-11-18T09:44:00+00:00","article_modified_time":"2025-12-10T09:58:29+00:00","og_image":[{"width":2048,"height":1536,"url":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/12\/KN2025-Branka.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@innothyrogenEU","twitter_site":"@innothyrogenEU","twitter_misc":{"Napisao\/la":"admin","Procijenjeno vrijeme \u010ditanja":"3 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\/#article","isPartOf":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\/"},"author":{"name":"admin","@id":"https:\/\/www.innothyrogen.eu\/hr\/#\/schema\/person\/f6b134e97e8e2d2e2289a7953108188b"},"headline":"InnoThyroGen na 62. onkolo\u0161kom kongresu u Beogradu","datePublished":"2025-11-18T09:44:00+00:00","dateModified":"2025-12-10T09:58:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\/"},"wordCount":640,"commentCount":0,"publisher":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/#organization"},"image":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\/#primaryimage"},"thumbnailUrl":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/12\/KN2025-Branka.jpg","articleSection":["Vijesti"],"inLanguage":"hr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\/","url":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\/","name":"InnoThyroGen na 62. onkolo\u0161kom kongresu u Beogradu","isPartOf":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\/#primaryimage"},"image":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\/#primaryimage"},"thumbnailUrl":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/12\/KN2025-Branka.jpg","datePublished":"2025-11-18T09:44:00+00:00","dateModified":"2025-12-10T09:58:29+00:00","description":"InnoThyroGen na 62. onkolo\u0161kom kongresu: Dr. Branka Zuki\u0107 odr\u017eala je predavanje i moderirala panel u Beogradu, podi\u017eu\u0107i vidljivost genomske medicine i ja\u010daju\u0107i suradnju izme\u0111u istra\u017eivanja i klini\u010dke prakse.","breadcrumb":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\/#breadcrumb"},"inLanguage":"hr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\/"]}]},{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\/#primaryimage","url":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/12\/KN2025-Branka.jpg","contentUrl":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/12\/KN2025-Branka.jpg","width":2048,"height":1536},{"@type":"BreadcrumbList","@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-62-onkoloskom-kongresu-u-beogradu\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Po\u010detna","item":"https:\/\/www.innothyrogen.eu\/hr\/"},{"@type":"ListItem","position":2,"name":"InnoThyroGen na 62. onkolo\u0161kom kongresu u Beogradu"}]},{"@type":"WebSite","@id":"https:\/\/www.innothyrogen.eu\/hr\/#website","url":"https:\/\/www.innothyrogen.eu\/hr\/","name":"InnoThyroGen EU Project","description":"Inovacije u zdravlju \u0161titnja\u010de s genomikom i prediktivnim algoritmima kroz suradni\u010dku izvrsnost","publisher":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.innothyrogen.eu\/hr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"hr"},{"@type":"Organization","@id":"https:\/\/www.innothyrogen.eu\/hr\/#organization","name":"InnoThyroGen EU projekt","url":"https:\/\/www.innothyrogen.eu\/hr\/","logo":{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/www.innothyrogen.eu\/hr\/#\/schema\/logo\/image\/","url":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/03\/logo_EMAIL_without_bacground_vertical.png","contentUrl":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/03\/logo_EMAIL_without_bacground_vertical.png","width":534,"height":520,"caption":"InnoThyroGen EU projekt"},"image":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61571994011521","https:\/\/x.com\/innothyrogenEU","https:\/\/www.linkedin.com\/company\/innothyrogen-eu-project\/"]},{"@type":"Person","@id":"https:\/\/www.innothyrogen.eu\/hr\/#\/schema\/person\/f6b134e97e8e2d2e2289a7953108188b","name":"admin","image":{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/secure.gravatar.com\/avatar\/7ddcd85f5d67b5a8ee8daedcc5e9afa1fef935b44ea366e04fb0f0185cea3977?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7ddcd85f5d67b5a8ee8daedcc5e9afa1fef935b44ea366e04fb0f0185cea3977?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7ddcd85f5d67b5a8ee8daedcc5e9afa1fef935b44ea366e04fb0f0185cea3977?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/www.innothyrogen.eu"],"url":"https:\/\/www.innothyrogen.eu\/hr\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/posts\/1936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/comments?post=1936"}],"version-history":[{"count":3,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/posts\/1936\/revisions"}],"predecessor-version":[{"id":1940,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/posts\/1936\/revisions\/1940"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/media\/1937"}],"wp:attachment":[{"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/media?parent=1936"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/categories?post=1936"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/tags?post=1936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}